• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    5/29/25 8:55:11 AM ET
    $ASPI
    Major Chemicals
    Industrials
    Get the next $ASPI alert in real time by email
    aspi_8k.htm
    0001921865false00019218652025-05-292025-05-29iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): May 29, 2025

     

    ASP Isotopes Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware

     

    001-41555

     

    87-2618235

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    601 Pennsylvania Avenue NW,

    South Building, Suite 900

    Washington, DC

     

    20004

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s telephone number, including area code: (202) 756-2245

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.01 per share

     

    ASPI

     

    The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

     Emerging growth company ☒ 

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

    Item 7.01. Regulation FD Disclosure.

     

    On May 29, 2025, ASP Isotopes Inc. (the “Company”) issued a letter to shareholders which summarizes the more significant milestones the Company has achieved during the past six months. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

     

    The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

     

    Item 9.01. Financial Statements and Exhibits.

     

    Exhibit No.

     

    Description

    99.1

     

    ASP Isotopes Inc. Letter to Shareholders, dated May 29, 2025.

    104

     

    Cover Page Interactive Date File (embedded within the Inline XBRL document)

     

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    ASP Isotopes Inc.

     

     

     

     

    Date: May 29, 2025

    By:

    /s/ Paul Mann

     

    Name:

    Paul Mann

     

     

    Title:

    Chief Executive Officer

     

     

     

    3

     

    Get the next $ASPI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASPI

    DatePrice TargetRatingAnalyst
    10/4/2024$4.50Buy
    Canaccord Genuity
    12/5/2023$3.25Buy
    H.C. Wainwright
    More analyst ratings

    $ASPI
    SEC Filings

    See more
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/11/25 8:48:50 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/4/25 10:27:08 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • SEC Form 424B5 filed by ASP Isotopes Inc.

      424B5 - ASP Isotopes Inc. (0001921865) (Filer)

      6/2/25 5:00:26 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Ainscow Robert bought 19,992 shares, increasing direct ownership by 2% to 919,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:49 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Executive Officer Mann Paul Elliot bought 39,984 shares, increasing direct ownership by 0.69% to 5,845,627 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:33 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Large owner Ak Jensen Investment Management Ltd bought $515,088 worth of shares (161,849 units at $3.18) (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/10/24 5:59:47 PM ET
      $ASPI
      Major Chemicals
      Industrials